There are high incidence rates of cardiovascular-related hospitalizations and mortality in patients with MPHV and poor anticoagulation.

Baseline small vessel disease score is the strongest predictor for incident infarcts among patients with a history of stroke.

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with a lower risk for incidental Parkinson disease among older adults with type 2 diabetes.

Older adults with untreated hypertension vs those with treated hypertension have a greater risk of developing Alzheimer disease.

Vaping is tied to lower cognitive scores in college students, according to a study presented at the annual meeting of the American Neurological Association.

While cardiovascular events are not associated with proton pump inhibitor treatment overall, cardiovascular events are frequent in GERD trials.

For patients with obesity, type 2 diabetes, and estimated glomerular filtration rate, metabolic surgery is associated with a lower risk for progression of kidney impairment.

The FDA has approved Flyrcado™ for positron emission tomography myocardial perfusion imaging under rest or stress in adult patients.

Social risk categories were associated with glycemic and quality of life-related outcomes among patients with type 2 diabetes.

Risk assessment models poorly predict VTE in critically ill patients and poorly identify those who would benefit from pneumatic compression.

Researchers have found that thrombolysis, with and without thrombectomy, is associated with decreased risk for epilepsy following stroke.

RSV infections affect a significant number of children under age 5, with considerable disease burden in primary care and emergency departments.